Amreen Husain, MD
Publication Details
-
Safety and efficacy of thalidomide in recurrent epithelial ovarian and peritoneal carcinoma.
Gynecol Oncol. 2006; (3): 919-23
Thalidomide is an anti-angiogenesis agent that has shown activity in some solid tumors. We performed a phase I clinical trial to determine the toxicity and potential efficacy of Thalidomide in recurrent epithelial ovarian carcinoma.
Help
Trial Administration